Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.884 | 95 | 1 | 1987 | 2020 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 94 | 0 | 1996 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
phenotype | 0.100 | None | 0.926 | 94 | 1 | 1996 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.989 | 92 | 1 | 1989 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.100 | None | 0.989 | 91 | 0 | 1994 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 90 | 0 | 2005 | 2020 | ||||||||
|
menin 1 | 0.444 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.922 | 90 | 0 | 1991 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 74 | 1 | 1991 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 71 | 0 | 2001 | 2020 | ||||||||
|
RUNX family transcription factor 3 | 0.459 | 0.731 | 0.84 |
|
phenotype | 0.100 | None | 0.986 | 70 | 0 | 2002 | 2020 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
phenotype | 0.100 | None | 1.000 | 69 | 0 | 2006 | 2020 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
phenotype | 0.100 | None | 0.985 | 67 | 0 | 2007 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.985 | 67 | 0 | 1996 | 2020 | ||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
phenotype | 0.100 | None | 0.938 | 64 | 0 | 2007 | 2020 | |||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.984 | 63 | 0 | 2000 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.100 | None | 0.935 | 62 | 0 | 2001 | 2020 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
phenotype | 0.100 | None | 0.967 | 61 | 0 | 2001 | 2020 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 0.983 | 59 | 0 | 2002 | 2020 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
phenotype | 0.100 | None | 0.966 | 58 | 1 | 1995 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
phenotype | 0.100 | None | 1.000 | 56 | 1 | 2009 | 2020 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 0.981 | 54 | 1 | 1999 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 1.000 | 53 | 0 | 1996 | 2020 | ||||||||
|
pyruvate kinase M1/2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 0.962 | 52 | 0 | 2010 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 51 | 1 | 2007 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.979 | 48 | 0 | 1999 | 2020 |